The pathophysiology of bronchial asthma involves reversible airway obstruction, mucus hypersecretion, an increase in vascular permeability, bronchial hyperreactivity, and airway inflammation. While infiltration of the lung with inflammatory cells such as neutrophils (PMNs), eosinophils, and mast cells has been observed in lavage fluid in both naturally occurring asthma and in human models of asthma, the role played by these cells in the lung in the pathogenesis of asthma is unknown. The overall goal of this proposal is to identify those aspects of the IgE-mediated inflammatory response that are modified in humans with atopic asthma. For example, it is not clear if this response is simply larger (an increased quantity of mediators released and cells recruited), if the response is more efficient (if the mediator release per cell is increased), or if the response is more effective (the end organ response to cells and mediators is increased). In order to test these hypotheses, atopic asthmatics and atopic nonasthmatic controls will undergo bronchoscopic antigen challenge into a localized portion of the lung with recruited inflammatory cells and mediators recovered at a later time by bronchoalveolar lavage (BAL). To test the hypothesis that the inflammatory response is larger, urinary leukotriene (LT) E4 levels immediately after challenge and total and differential cell counts in BAL fluid from the antigen challenged segment 24 hr after local antigen challenge will be quantitated. The hypothesis will also be tested that LTB4 is responsible for attracting PMNs after antigen challenge. To test the hypothesis that the inflammatory response is more efficient (cells recruited to the lungs of asthmatics are more """"""""inflammatory"""""""" than those from nonasthmatics, i.e. they have been """"""""primed"""""""" for an increase in mediator release), the in vitro release of mediators from neutrophils, eosinophils and macrophages recruited to the lung by local antigen challenge; a quantitative cytochemical analysis of granule content of neutrophils, eosinophils, and macrophages recovered by BAL; and the concentrations of neutrophil elastase, eosinophil products (major basic protein, cationic protein), and macrophage beta-glucuronidase in BAL fluid will be determined. The mechanism by which macrophages are primed for an increase in oxidant release will also be determined. To test the hypothesis that the inflammatory response is more effective in producing pathophysiologic changes in asthmatic than in nonasthmatic subjects, the airway inflammatory response and the influx of albumin into the airways will be determined. the hypothesis that eosinophils are primarily responsible for lung injury in this model will also be tested. These studies will provide important information concerning the function of inflammatory cells in the pathogenesis of allergic bronchial asthma. In addition, they will provide crucial information needed in order to develop novel strategies for the treatment of asthma using antiinflammatory agents.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI024509-05
Application #
3137556
Study Section
Lung Biology and Pathology Study Section (LBPA)
Project Start
1986-09-15
Project End
1996-03-31
Budget Start
1993-04-01
Budget End
1994-03-31
Support Year
5
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Thomas Jefferson University
Department
Type
Schools of Medicine
DUNS #
061197161
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Hastie, Annette T; Wu, Min; Foster, Gayle C et al. (2006) Alterations in vasodilator-stimulated phosphoprotein (VASP) phosphorylation: associations with asthmatic phenotype, airway inflammation and beta2-agonist use. Respir Res 7:25
Batra, V; Musani, A I; Hastie, A T et al. (2004) Bronchoalveolar lavage fluid concentrations of transforming growth factor (TGF)-beta1, TGF-beta2, interleukin (IL)-4 and IL-13 after segmental allergen challenge and their effects on alpha-smooth muscle actin and collagen III synthesis by primary human lu Clin Exp Allergy 34:437-44
Peters, Stephen P (2003) Heterogeneity in the pathology and treatment of asthma. Am J Med 115 Suppl 3A:49S-54S
Hastie, Annette T; Batra, Vikas; Khurana, Sandhya et al. (2003) Modulation of vasodilator-stimulated phosphoprotein in vivo in human epithelial cells by segmental allergen challenge and beta2-agonist therapy. Chest 123:377S
Batra, Vikas; Khurana, Sandhya; Musani, Ali I et al. (2003) Concentration of cytokines and growth factors in BAL fluid after allergen challenge in asthmatics and their effect on alpha-smooth muscle actin and collagen III synthesis by human lung fibroblasts. Chest 123:398S-9S
Niazi, Sultan; Robertson, Noreen M; Agrawal, Ashish et al. (2003) Overlap between death receptor and non-receptor-mediated mechanisms during apoptosis in human eosinophils. Chest 123:345S
Peters, Stephen P (2003) Leukotriene receptor antagonists in asthma therapy. J Allergy Clin Immunol 111:S62-70
Robertson, Noreen M; Zangrilli, James G; Steplewski, Andrzej et al. (2002) Differential expression of TRAIL and TRAIL receptors in allergic asthmatics following segmental antigen challenge: evidence for a role of TRAIL in eosinophil survival. J Immunol 169:5986-96
Loza, Matthew J; Peters, Stephen P; Zangrilli, James G et al. (2002) Distinction between IL-13+ and IFN-gamma+ natural killer cells and regulation of their pool size by IL-4. Eur J Immunol 32:413-23
Hastie, Annette T; Kraft, Walter K; Nyce, Kristin B et al. (2002) Asthmatic epithelial cell proliferation and stimulation of collagen production: human asthmatic epithelial cells stimulate collagen type III production by human lung myofibroblasts after segmental allergen challenge. Am J Respir Crit Care Med 165:266-72

Showing the most recent 10 out of 44 publications